CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 24 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,178 | +4.9% | 12,312 | +2.6% | 0.00% | – |
| Q1 2023 | $6,840 | +0.1% | 12,000 | +17.6% | 0.00% | – |
| Q4 2022 | $6,834 | -79.9% | 10,200 | -67.6% | 0.00% | – |
| Q2 2022 | $34,000 | -48.5% | 31,519 | +46.5% | 0.00% | – |
| Q1 2022 | $66,000 | -69.7% | 21,513 | -61.7% | 0.00% | – |
| Q4 2021 | $218,000 | +10.7% | 56,242 | +50.2% | 0.00% | – |
| Q3 2021 | $197,000 | +103.1% | 37,440 | +173.3% | 0.00% | – |
| Q1 2021 | $97,000 | – | 13,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |